Current Perspectives on Thyroid Nodule Evaluation: Integrating Cytomorphology, Ultrasound Risk Stratification, and Molecular Testing
Modern Pathology · 2026
DOI: 10.1016/j.modpat.2026.101039 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Modern Pathology, 2026. Verfasst von Marc P Pusztaszeri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. Electronic address: marc.pusztaszeri@mcgill.ca. Hauptthemen laut MEDLINE: Thyroid Nodule, Molecular Diagnostic Techniques, Thyroid Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Fine-needle aspiration biopsy (FNAB) remains the cornerstone of preoperative evaluation of thyroid nodules and represents one of the most enduring and successful applications of cytopathology in clinical medicine. Over the past decade, however, the role of thyroid FNAB has evolved considerably. This transformation reflects advances in ultrasound-based risk stratification systems and refinements in cytologic reporting, culminating in the third edition of the Bethesda System for Reporting Thyroid Cytopathology and ongoing international harmonization initiatives, including the forthcoming World Health Organization Reporting System for Head and Neck Cytopathology, the integration of molecular diagnostic testing into routine workflows, and major revisions in thyroid tumor classification introduced in the fifth edition of the WHO Classification of Endocrine and Neuroendocrine Tumours. Collectively, these developments have shifted thyroid FNAB from a predominantly morphologic screening modality to a central component of a multidimensional, precision-based diagnostic pathway. In contemporary practice, thyroid FNAB operates within an integrated clinical framework that combines imaging-based risk assessment, cytomorphologic interpretation, molecular testing, and risk-adapted management strategies. This review summarizes the current status of thyroid FNAB with emphasis on FNAB indications, specimen adequacy, cytomorphologic interpretation within the Bethesda framework, management of indeterminate thyroid nodules, and the expanding role of molecular classifiers. Emerging diagnostic and management approaches, including artificial intelligence, radiogenomics, active surveillance, and ablation therapies, are also discussed. Attention is given to the practical implications of these advances for surgical pathologists and cytopathologists who are engaged in multidisciplinary thyroid nodule management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. Electronic address: marc.pusztaszeri@mcgill.ca.
- Department of Pathology, University of Pennsylvania Medical Center, Perelman School of Medicine, Philadelphia, Pennsylvania.
Zitieren
APA
Pusztaszeri, M. P., & Baloch, Z. W. (2026). Current Perspectives on Thyroid Nodule Evaluation: Integrating Cytomorphology, Ultrasound Risk Stratification, and Molecular Testing. Modern Pathology. https://doi.org/10.1016/j.modpat.2026.101039
Vancouver
Pusztaszeri MP, Baloch ZW. Current Perspectives on Thyroid Nodule Evaluation: Integrating Cytomorphology, Ultrasound Risk Stratification, and Molecular Testing. Modern Pathology. 2026. doi:10.1016/j.modpat.2026.101039
BibTeX
@article{Pusztaszeri2026,
author = {Pusztaszeri, Marc P and Baloch, Zubair W},
title = {Current Perspectives on Thyroid Nodule Evaluation: Integrating Cytomorphology, Ultrasound Risk Stratification, and Molecular Testing},
journal = {Modern Pathology},
year = {2026},
doi = {10.1016/j.modpat.2026.101039}
}
EUVIMED